Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
One Bullion Limited to Participate in PDAC 2026, The World’s Premier Mineral Exploration & Mining Convention, March 1-4, 2026
-
Bombardier Announces Notice of Redemption for All Remaining Outstanding 6.000% Senior Notes due 2028
-
Crescent Biopharma Announces Grants of Inducement Awards
-
Reunion Neuroscience to Participate in Upcoming Investor Conferences
-
Recording of AB Akola Group Investor Webinar Presenting the 6-Month Unaudited Results for the 2025/2026 Financial Year
-
Navios Maritime Partners L.P. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2025
-
Kane Biotech Expands Commercial Activities in the United States
-
Jiuzi Holdings in Discussions with Private Investors to Expand Fundraising, Plans to Increase Scale to $100 Million at No Less Than $2 Per Share, Building on Completed $60 Million Private Placement
-
Appian Announces Fourth Quarter and Full Year 2025 Financial Results
-
Labrador Gold Responds to Dissident’s Vote Contingent Dividend — Warns Shareholders This is a Desperate Repeat of the GrowMax Campaign Playbook
-
NetraMark Closes Final Tranche of $3.5 Million Private Placement
-
LKQ Corporation Announces Results for Fourth Quarter and Full Year 2025
-
Supremex Announces Q4 and Year-End 2025 Results
-
Loblaw Accelerates the Adoption of AI-driven Digital Commerce in Canada with Google Collaboration
-
Alta Equipment Group Announces Date of Fourth Quarter and Full Year 2025 Financial Results Release, Conference Call and Webcast
-
HPQ Receives First Purchase Order for 50 kg of Fumed Silica for Advanced Customer Testing
-
Brady Corporation Reports Fiscal 2026 Second Quarter Results and Raises the Low End of its Fiscal 2026 EPS Guidance
-
Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
-
Sprott Announces Year Ended 2025 Results
-
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
-
BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer’s Dementia
-
Abcourt announces its financial results for the quarter ended December 31, 2025
-
AmpliTech Expands Global ORAN 5G Cell Tower Equipment Portfolio with New Mid-Band Solutions Ahead of MWC 2026
-
Kymera Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
-
VR Submits Drill Permit Application for its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada
-
Freehand Recognized in the 2026 Gartner® Market Guide for Freight Audit and Payment Providers
-
Pool Corporation Reports Year End and Fourth Quarter 2025 Results; Provides 2026 Earnings Guidance
-
Mobilicom Secures Design Win and Initial Order to Integrate Cybersecure Systems into New ISR Drone Platform
-
Hitachi Rail Invests C$30 Million in New Canadian Headquarters
-
Bitdeer Announces Proposed Private Placement of US$300.0 Million of Convertible Senior Notes
-
Bitdeer Announces Proposed Registered Direct Offering of Class A Ordinary Shares
-
Discovery Reports Strong Earnings Growth and Cash Generation in Q4 2025
-
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
-
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
-
Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
-
Istios Health Expands Into Nephrology With Three Practice Partnerships
-
Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
-
Advantage Solutions Announces Date for its Fourth Quarter and Full Year 2025 Financial Results and Conference Call
-
Brunswick Exploration Identifies Seven New Spodumene Targets and Stakes Additional Claims at Anatacau Main
-
Incora’s Hari Kumar Rajendran to Deliver Keynote at Infosys Manufacturing AI Event in Dallas
-
PyroGenesis Confirms Third-Party Verification of Its Fumed Silica: Successfully Meets Major Requirement for Proposed Joint Venture
-
Woof Gang Expands Retail Experience with Toys, Cosmetics and Celebratory Treats for Every Occasion
-
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Biomea Fusion to Participate at Upcoming Investor Conferences
-
OTC Markets Group Welcomes Golf Entertainment Group Inc. to OTCQX
-
Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting
-
Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026
-
Passage Bio to Participate in Upcoming Investor Conferences
-
AS Tallink Grupp Investor Webinar introducing the results of the fourth quarter and full year 2025
